Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
153M
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
4.22M
-
Shares change
-
+452K
-
Total reported value, excl. options
-
$85.6M
-
Value change
-
+$9.21M
-
Number of buys
-
22
-
Number of sells
-
-23
-
Price
-
$20.31
Significant Holders of BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) as of Q1 2021
52 filings reported holding BDSX - BIODESIX INC - Common Stock, par value $0.001 per share as of Q1 2021.
BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.22M shares
of 153M outstanding shares and own 2.75% of the company stock.
Largest 10 shareholders include Birchview Capital, LP (1.1M shares), Asymmetry Capital Management, L.P. (444K shares), KORNITZER CAPITAL MANAGEMENT INC /KS (326K shares), VANGUARD GROUP INC (268K shares), PUTNAM INVESTMENTS LLC (259K shares), ORACLE INVESTMENT MANAGEMENT INC (236K shares), MILLENNIUM MANAGEMENT LLC (201K shares), BlackRock Inc. (160K shares), FRED ALGER MANAGEMENT, LLC (139K shares), and RTW INVESTMENTS, LP (125K shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.